TPI1 and hepatocellular carcinoma: Compared to normal samples, HAGs with deletions displayed lower expressions in HCC (e.g., ANGPTL4 and TPI1), while HAGs with amplification might promote mRNA expressions (e.g., MRPS17 and NDRG1).